Public Company Management Corporation is a development stage company. The Company's business plan is to seek new business opportunities or to engage in a merger or acquisition with an unidentified company. The Companyâ€™s operations have been limited to seeking a potential business combination and has had no revenue from operations.

Employees

Sector

Investment Holding Companies

More about the company

Market Closed - OTC Markets 00:25:18 14/05/2026 HKT			5-day change	1st Jan Change
0.4490 ^USD	+36.06%		+79.60%	+113.81%

08-05	Public Company Management Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026	CI
05-12	Public Company Management Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026	CI

Market Cap	8.57M 7.37M 6.94M 6.34M 11.86M 809M 11.89M 81.98M 31.81M 415M 32.18M 31.48M 1.34B	P/E 2024	-89.4x	P/E 2025	-132x
Enterprise Value	8.68M 7.47M 7.03M 6.42M 12.02M 820M 12.05M 83.09M 32.24M 421M 32.61M 31.9M 1.36B	EV / Sales 2024	-	EV / Sales 2025	-
Free-Float	30.14%	Yield 2024 *	-	Yield 2025	-

08-05	Public Company Management Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026	CI
05-12	Public Company Management Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026	CI
02-25	Public Company Management Corp. entered into a non-binding letter of intent to acquire Physicians Capital Management Corporation from Conrad Ivie, M.D.	CI
02-18	Public Company Management Corp. Reports Earnings Results for the First Quarter Ended December 31, 2025	CI
02-05	Public Company Management Corp. Reports Earnings Results for the Full Year Ended September 30, 2025	CI
02-04	Public Company Management Corp. Auditor Raises 'Going Concern' Doubt	CI
15/08/25	Public Company Management Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2025	CI
09/05/25	Public Company Management Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025	CI
12/02/25	Public Company Management Corp. Reports Earnings Results for the First Quarter Ended December 31, 2024	CI
13/01/25	Public Company Management Corp. Reports Earnings Results for the Full Year Ended September 30, 2024	CI
13/01/25	Public Company Management Corp. Auditor Raises 'Going Concern' Doubt	CI
09/08/24	Public Company Management Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2024	CI
10/05/24	Public Company Management Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI

02-05	Public Management : Annual Report for Fiscal Year Ending September 30, 2025 (Form 10-K)	PU
13/01/25	Public Management : Annual Report for Fiscal Year Ending September 30, 2024 (Form 10-K)	PU
03/08/23	Public Management : Change in Certifying Accountants - Form 8-K	PU
14/03/23	PUBLIC CO MANAGEMENT CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers, Other Events (form 8-K)	AQ
06/03/23	PUBLIC CO MANAGEMENT CORP : Change in Directors or Principal Officers (form 8-K)	AQ

Public Company Management Corp. Stock

Stocks

PCMC

US7443921017

Investment Holding Companies

Valuation : Public Company Management Corp.

Chart: Public Company Management Corp.

Latest news : Public Company Management Corp.

Press Releases : Public Company Management Corp.

Quotes and Performance

Price Extremes

Managers and Directors : Public Company Management Corp.

Shell Companies

Financials

Company Profile

1 day	+36.06%
1 week	+79.60%
Current month	+79.60%
1 month	+12.25%
3 months	+9.51%
6 months	+21.35%
Current year	+113.81%

1 month	0.25	0.45
Current year	0.21	0.47
1 year	0.21	0.5
3 years	0.05	0.68
5 years	0	0.68
10 years	0	0.68

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PUBLIC COMPANY MANAGEMENT CORP.	+36.06%	+79.60%	-10.20%	+461.95%	8.57M
PASQAL HOLDING SA	-18.36%	-58.35%	-	-	1.69B
CHURCHILL CAPITAL CORP XI	-3.04%	-4.08%	-	-	746M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	0.00%	+0.30%	-	-	648M
BAIN CAPITAL GSS INVESTMENT CORP.	+0.34%	+0.34%	-	-	602M
CHURCHILL CAPITAL CORP XII	-0.70%	-1.11%	-	-	595M
CANTOR EQUITY PARTNERS IV, INC.	+0.10%	+0.39%	+2.97%	-	594M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.87%	-0.78%	-	-	564M
CENTIEL AG	+4.87%	-4.44%	+250.00%	-79.71%	564M
Average	+2.04%	-7.53%	+80.92%	+191.12%	668.12M
Weighted average by Cap.	-5.14%	-17.40%	+122.31%	-71.61%

	2024	2025
Net sales	-	-
Net income	-75.52K -64.98K -61.14K -55.85K -104K -7.13M -105K -722K -280K -3.66M -284K -277K -11.78M	-104K -89.33K -84.05K -76.78K -144K -9.8M -144K -993K -385K -5.03M -390K -381K -16.2M
Net Debt	425K 366K 344K 314K 588K 40.12M 590K 4.07M 1.58M 20.59M 1.6M 1.56M 66.32M	116K 99.47K 93.59K 85.49K 160K 10.91M 160K 1.11M 429K 5.6M 434K 425K 18.04M